期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Structural basis of SARS-CoV-2 3CL^pro and anti-COVID-19 drug discovery from medicinal plants 被引量:30
1
作者 Muhammad Tahir ul Qamar safar malqahtani +1 位作者 Mubarak AAlamri Ling-Ling Chen 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2020年第4期313-319,共7页
The recent pandemic of coronavirus disease 2019(COVID-19)caused by SARS-CoV-2 has raised global health concerns.The viral 3-chymotrypsin-like cysteine protease(3CL^pro)enzyme controls coronavirus replication and is es... The recent pandemic of coronavirus disease 2019(COVID-19)caused by SARS-CoV-2 has raised global health concerns.The viral 3-chymotrypsin-like cysteine protease(3CL^pro)enzyme controls coronavirus replication and is essential for its life cycle.3CL^pro is a proven drug discovery target in the case of severe acute respiratory syndrome coronavirus(SARS-CoV)and Middle East respiratory syndrome coronavirus(MERS-CoV).Recent studies revealed that the genome sequence of SARS-CoV-2 is very similar to that of SARS-CoV.Therefore,herein,we analysed the 3CL^pro sequence,constructed its 3D homology model,and screened it against a medicinal plant library containing 32,297 potential anti-viral phytochemicals/traditional Chinese medicinal compounds.Our analyses revealed that the top nine hits might serve as potential anti-SARS-CoV-2 lead molecules for further optimisation and drug development process to combat COVID-19. 展开更多
关键词 CORONAVIRUS SARS-CoV-2 COVID-19 Natural products Protein homology modelling Molecular docking Molecular dynamics simulation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部